Literature DB >> 29669278

Sarm1/Myd88-5 Regulates Neuronal Intrinsic Immune Response to Traumatic Axonal Injuries.

Qi Wang1, Shan Zhang2, Tingting Liu1, Huanhuan Wang3, Kaili Liu4, Qiujun Wang5, Wenwen Zeng6.   

Abstract

Traumatic injuries can trigger inflammatory reactions, leading to profound neuropathological consequences. However, the immune capacity of neurons, distinct from that of immune cells or glial cells, in response to traumatic insults remains to be fully characterized. In this study, we demonstrate that neurons can detect, cell autonomously, distant axonal damage, resulting in rapid production of a specific collection of cytokines and chemokines. This neuronal immune response appears spatially and temporally separated from injury-induced axon degeneration. We then identify through the genetic screen that this immune response is regulated by TIR-domain adaptor Sarm1/Myd88-5. We further show that Sarm1 functions through the downstream Jnk-c-Jun signal, and blockage of this Sarm1-Jnk-c-Jun pathway effectively abolishes the recruitment of immune cells to injury-afflicted neural tissues. We therefore uncover the key function of the Sarm1 signaling pathway, independent of its known role in axon degeneration, in the neuronal intrinsic immune response to traumatic axonal injuries.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sarm1; neuroinflammation; neuronal intrinsic immune response; traumatic injuries

Mesh:

Substances:

Year:  2018        PMID: 29669278     DOI: 10.1016/j.celrep.2018.03.071

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  27 in total

Review 1.  Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.

Authors:  Heather S Loring; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2019-11-21       Impact factor: 8.116

2.  Analysis of the immune response to sciatic nerve injury identifies efferocytosis as a key mechanism of nerve debridement.

Authors:  Ashley L Kalinski; Choya Yoon; Lucas D Huffman; Patrick C Duncker; Rafi Kohen; Ryan Passino; Hannah Hafner; Craig Johnson; Riki Kawaguchi; Kevin S Carbajal; Juan Sebastian Jara; Edmund Hollis; Daniel H Geschwind; Benjamin M Segal; Roman J Giger
Journal:  Elife       Date:  2020-12-02       Impact factor: 8.140

Review 3.  NAD+ metabolism and its roles in cellular processes during ageing.

Authors:  Anthony J Covarrubias; Rosalba Perrone; Alessia Grozio; Eric Verdin
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-22       Impact factor: 94.444

4.  DLK regulates a distinctive transcriptional regeneration program after peripheral nerve injury.

Authors:  Jung Eun Shin; Hongseok Ha; Yoon Ki Kim; Yongcheol Cho; Aaron DiAntonio
Journal:  Neurobiol Dis       Date:  2019-02-05       Impact factor: 5.996

Review 5.  Axon injury signaling and compartmentalized injury response in glaucoma.

Authors:  Stephanie B Syc-Mazurek; Richard T Libby
Journal:  Prog Retin Eye Res       Date:  2019-07-10       Impact factor: 21.198

Review 6.  SARM1 can be a potential therapeutic target for spinal cord injury.

Authors:  Qicheng Lu; Benson O A Botchway; Yong Zhang; Tian Jin; Xuehong Liu
Journal:  Cell Mol Life Sci       Date:  2022-02-28       Impact factor: 9.261

Review 7.  The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease.

Authors:  Matthew D Figley; Aaron DiAntonio
Journal:  Curr Opin Neurobiol       Date:  2020-04-17       Impact factor: 6.627

8.  Injury-Induced Inhibition of Bystander Neurons Requires dSarm and Signaling from Glia.

Authors:  Jiun-Min Hsu; Yunsik Kang; Megan M Corty; Danielle Mathieson; Owen M Peters; Marc R Freeman
Journal:  Neuron       Date:  2020-12-08       Impact factor: 17.173

9.  Sarm1 is Essential for Anesthesia-Induced Neuroinflammation and Cognitive Impairment in Aged Mice.

Authors:  Huimei Lin; Zhenming Kang; Shunyuan Li; Jingyang Zeng; Jie Zhao
Journal:  Cell Mol Neurobiol       Date:  2021-01-12       Impact factor: 5.046

Review 10.  Programmed axon degeneration: from mouse to mechanism to medicine.

Authors:  Michael P Coleman; Ahmet Höke
Journal:  Nat Rev Neurosci       Date:  2020-03-09       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.